KORU Medical (KRMD) CCO Adam Kalbermatten Receives Award

What Happened

• Adam R. Kalbermatten, Chief Commercial Officer of KORU Medical Systems, had 75,000 restricted stock units (RSUs) convert to common stock on July 28, 2026 (reported on a Form 4 filed Aug 6, 2026). The conversion (coded M) resulted in 75,000 shares issued at $0 exercise price. To satisfy tax withholding (coded F), 25,483 of those shares were withheld at $4.26 per share for a reported withholding value of $108,558, leaving a net 49,517 shares issued to him.

Key Details

• Transaction date: 2026-07-28 (reported on Form 4 filed 2026-08-06).
• Conversion: 75,000 shares acquired (code M) at $0.00 exercise price.
• Tax withholding: 25,483 shares withheld (code F) at $4.26/share for $108,558.
• Net newly issued to insider: 75,000 − 25,483 = 49,517 shares.
• Shares owned after transaction: Not specified in the provided filing.
• Footnotes: F1 = RSUs converted to one share per unit upon vesting. F2 = Shares withheld to satisfy tax obligations.
• Timeliness: The Form 4 was filed on Aug 6 for a July 28 transaction, which appears later than the standard Form 4 deadline (generally two business days); late filing may reduce the timeliness of disclosure for investors.

Context

• This was an award/vesting event (RSU conversion), not an open-market purchase or discretionary sale; withholding of shares to cover taxes is a routine administrative step (a cashless-like settlement). Such conversions increase insider's share count (net) but do not necessarily signal a change in insider sentiment.